Atlas Trials

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

Clinical trial NCT01513603 · UNKNOWN

Trial details

NCT number
NCT01513603
Sponsor
New York Medical College
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaLymphoblastic LymphomaBurkitts Leukemia/LymphomaChronic Myelogenous Leukemia
Start date
2012-01-01
Primary completion
2014-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.